SCHEMBL2490779

SCHEMBL2490779

COc1ccccc1N(CCO)C(c1ccccc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.45
SLC6A4 P31645 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.41
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
ATM Q13315 1/20 0.38
SLC6A9 P48067 1/20 0.36
AGTR1 P30556 1/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
IDO1 P14902 1/20 0.36
TDO2 P48775 1/20 0.36
MAPK1 P28482 1/20 0.36
GAA P10253 1/20 0.36
ESR1 P03372 1/20 0.36
HTR1A P08908 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2492865 0.93 SLC6A2 (0.44) SLC6A2SLC6A4L3MBTL1MEN1KMT2A
SCHEMBL2495689 0.81 SLC6A2 (0.42) SLC6A2SLC6A4L3MBTL1MEN1KMT2A
SCHEMBL8713532 0.78 SIGMAR1 (0.41) SLC6A2SLC6A4CYP1A2
SCHEMBL15674317 0.77 SLC1A5 (0.43) SLC6A2SLC6A4L3MBTL1KMT2ASLC6A9
SCHEMBL15674316 0.77 SLC1A5 (0.43) SLC6A2SLC6A4L3MBTL1KMT2ASLC6A9
SCHEMBL2492244 0.76 MEN1 (0.40) L3MBTL1MEN1KMT2ALMNAESR1
SCHEMBL2492138 0.76 SLC6A2 (0.45) SLC6A2SLC6A4L3MBTL1MEN1KMT2A
SCHEMBL3779042 0.75 CA1 (0.44) SLC6A2SLC6A4MEN1KMT2AAGTR1
SCHEMBL15465790 0.74 MEN1 (0.49) SLC6A2SLC6A4MEN1KMT2AAGTR1
SCHEMBL7594235 0.73 KDM4E (0.42) SLC6A2SLC6A4L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH SLC6A2 709/4885SLC6A4 1710/4885L3MBTL1 895/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 SLC6A2 641/4885SLC6A4 1431/4885L3MBTL1 644/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R SLC6A2 683/4885SLC6A4 1496/4885L3MBTL1 680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.